ARVINAS, INC. Uncategorized Contracts & Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated
ARVINAS, INC.
Pharmaceuticals
DE
2023
Master In Vitro Diagnostics Agreement
ARVINAS, INC.
Pharmaceuticals
2022
Investor Agreement, dated July 21, 2021, by and between Arvinas, Inc. and Pfizer, Inc
ARVINAS, INC.
Pharmaceuticals
DE
2021
Description of the Registrants Securities Registered Under Section 12 of the Exchange Act
ARVINAS, INC.
Pharmaceuticals
DE
2020
Investor Agreement between the Registrant and Bayer AG, dated July 16, 2019
ARVINAS, INC.
Pharmaceuticals
DE
2019
Option Agreement between Arvinas Operations, Inc. and Bayer CropScience LP, dated June 3, 2019
ARVINAS, INC.
Pharmaceuticals
DE
2019
Commitment Agreement between Arvinas Operations, Inc., Protag LLC, and Bayer CropScience LP, dated June 3, 2019
ARVINAS, INC.
Pharmaceuticals
DE
2019
Sponsored Research Agreement between The Silverstein Foundation for Parkinsons with GBA and Arvinas, Inc., dated March 7, 2018
ARVINAS, INC.
Pharmaceuticals
NY
2018
Form of Plan of Conversion
ARVINAS, INC.
Pharmaceuticals
DE
2018
Sponsored Research Agreement between The Silverstein Foundation for Parkinsons with GBA and Arvinas, Inc., dated March 7, 2018
ARVINAS, INC.
Pharmaceuticals
NY
2018
Corporate Sponsored Research Agreement between Yale University and Arvinas, Inc., dated July 1, 2016, as amended by Amendment No. 1, dated April 1, 2018
ARVINAS, INC.
Pharmaceuticals
CT
2018
Second Amended and Restated Put Agreement among the Registrant, Connecticut Innovations, Incorporated and the other parties thereto, dated March 29, 2018
ARVINAS, INC.
Pharmaceuticals
CT
2018